Cargando…
Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Association for the Study of the Liver. Published by Elsevier Ireland Ltd.
2001
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172842/ https://www.ncbi.nlm.nih.gov/pubmed/11682040 http://dx.doi.org/10.1016/S0168-8278(01)00184-2 |
| _version_ | 1783524336704946176 |
|---|---|
| author | Craxì, Antonio Lo Iacono, Oreste |
| author_facet | Craxì, Antonio Lo Iacono, Oreste |
| author_sort | Craxì, Antonio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7172842 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2001 |
| publisher | European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71728422020-04-22 Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck? Craxì, Antonio Lo Iacono, Oreste J Hepatol Article European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. 2001-10 2001-09-25 /pmc/articles/PMC7172842/ /pubmed/11682040 http://dx.doi.org/10.1016/S0168-8278(01)00184-2 Text en Copyright © 2001 European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Craxì, Antonio Lo Iacono, Oreste Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck? |
| title | Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck? |
| title_full | Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck? |
| title_fullStr | Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck? |
| title_full_unstemmed | Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck? |
| title_short | Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck? |
| title_sort | amantadine for chronic hepatitis c: a magic bullet or yet another dead duck? |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172842/ https://www.ncbi.nlm.nih.gov/pubmed/11682040 http://dx.doi.org/10.1016/S0168-8278(01)00184-2 |
| work_keys_str_mv | AT craxiantonio amantadineforchronichepatitiscamagicbulletoryetanotherdeadduck AT loiaconooreste amantadineforchronichepatitiscamagicbulletoryetanotherdeadduck |